FGH10019
FGH10019 is a novel sterol regulatory element-binding protein (SREBP) inhibitor with IC50 of 1 μM.
Product Specifications
CAS Number
[1046045-61-7]
UNSPSC
12352005
Target
Fatty Acid Synthase (FASN)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/FGH10019.html
Purity
99.87
Solubility
DMSO : ≥ 38 mg/mL
Smiles
CS(=O)(NC1=CC=C(C2=CSC(C3=CC(CCC)=NC=C3)=N2)C=C1)=O
Molecular Formula
C18H19N3O2S2
Molecular Weight
373.49
References & Citations
[1]Kamisuki S, et al. Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins. J Med Chem. 2011 Jul 14;54 (13) :4923-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![(4S,5R) -5-[3,5-Bis (trifluoromethyl) phenyl]-4-methyl-1,3-oxazolidin-2-one](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
434165-01 100 mg
(4S,5R) -5-[3,5-Bis (trifluoromethyl) phenyl]-4-methyl-1,3-oxazolidin-2-one
Ask
View Details 434165-02 250 mg
(4S,5R) -5-[3,5-Bis (trifluoromethyl) phenyl]-4-methyl-1,3-oxazolidin-2-one
Ask
View Details 